Form D · Biotechnology
Sun Genomics, Inc.
San Diego, CA · CIK 0001754197
Offering snapshot reported Jan 3, 2019 · SEC filing
- Reported sold
- $2.97M Offering amount: $3.82M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 21, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 3, 2019 | Initial | $2,965,687 | No comparison | 20 | SEC filing |
| Sep 25, 2018 | Initial | $625,000 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-329554
Source: Form D, filed Jan 3, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Suneer Jain | Director, Executive |
| Randy Socol | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10210 Campus Point Drive Suite 150
San Diego, CA, 92121
San Diego, CA, 92121